CONTRIBUTION OF DIRECT AND INDIRECT RECOGNITION PATHWAYS TO T-CELL ALLOREACTIVITY

被引:215
作者
LIU, Z [1 ]
SUN, YK [1 ]
XI, YP [1 ]
MAFFEI, A [1 ]
REED, E [1 ]
HARRIS, P [1 ]
SUCIUFOCA, N [1 ]
机构
[1] COLUMBIA UNIV,DEPT PATHOL,630 W 168TH ST,P&S 14-403,NEW YORK,NY 10032
关键词
D O I
10.1084/jem.177.6.1643
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cells from an HLA-DR11/DR12 responder were stimulated in mixed lymphocyte culture with cells carrying the DR1 antigen. After priming, T cells proliferated in response to both DR1-positive-stimulating cells and a peptide derived from a polymorphic region of the HLA-DRbeta1*0101 chain presented by responder's antigen-presenting cells (APC). The dominant epitope recognized by the primed T cells corresponded to residue 21-42 and was presented by the responder's HLA-DR12 antigen. The DR1 peptide-reactive T cells express T cell receptor Vbeta3. The results demonstrate that allopeptides derived from the processing and presentation of donor major histocompatibility complex molecules by host-derived APC trigger alloreactivity. The frequency of T cells engaged in the indirect pathway of allorecognition is about 100-fold lower than that of T cells participating in the direct recognition of native HLA-DR antigen. However, indirect allorecognition may play an important role in chronic allograft rejection, a phenomenon that is mediated by the activation of T helper cells and of alloantibody-producing B cells.
引用
收藏
页码:1643 / 1650
页数:8
相关论文
共 26 条
  • [1] ALLELIC VARIATION IN THE DR SUBREGION OF THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX
    BELL, JI
    DENNEY, D
    FOSTER, L
    BELT, T
    TODD, JA
    MCDEVITT, HO
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (17) : 6234 - 6238
  • [2] DONOR MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) PEPTIDES ARE PRESENTED BY RECIPIENT MHC MOLECULES DURING GRAFT-REJECTION
    BENICHOU, G
    TAKIZAWA, PA
    OLSON, CA
    MCMILLAN, M
    SERCARZ, EE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) : 305 - 308
  • [3] IMMUNOGENICITY AND TOLEROGENICITY OF SELF-MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDES
    BENICHOU, G
    TAKIZAWA, PA
    HO, PT
    KILLION, CC
    OLSON, CA
    MCMILLAN, M
    SERCARZ, EE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (05) : 1341 - 1346
  • [4] HIGH DETERMINANT DENSITY MAY EXPLAIN THE PHENOMENON OF ALLOREACTIVITY
    BEVAN, MJ
    [J]. IMMUNOLOGY TODAY, 1984, 5 (05): : 128 - 130
  • [5] PROCESSED MHC CLASS-I ALLOANTIGEN AS THE STIMULUS FOR CD4+ T-CELL DEPENDENT ANTIBODY-MEDIATED GRAFT-REJECTION
    BRADLEY, JA
    MOWAT, AM
    BOLTON, EM
    [J]. IMMUNOLOGY TODAY, 1992, 13 (11): : 434 - 438
  • [6] MOLECULAR MIMICRY IN LIVER-DISEASE
    BURROUGHS, AK
    BUTLER, P
    STERNBERG, MJE
    BAUM, H
    [J]. NATURE, 1992, 358 (6385) : 377 - 378
  • [7] CYTOTOXIC T-CELL RECOGNITION OF AN ENDOGENOUS CLASS-I HLA PEPTIDE PRESENTED BY A CLASS-II HLA MOLECULE
    CHEN, BP
    MADRIGAL, A
    PARHAM, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (03) : 779 - 788
  • [8] T-CELLS SENSITIZED TO SYNTHETIC HLA-DR3 PEPTIDE GIVE EVIDENCE OF CONTINUOUS PRESENTATION OF DENATURED HLA-DR3 MOLECULES BY HLA-DP
    DEKOSTER, HS
    ANDERSON, DC
    TERMIJTELEN, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (03) : 1191 - 1196
  • [9] REJECTION OF SKIN ALLOGRAFTS BY INDIRECT ALLORECOGNITION OF DONOR CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDES
    FANGMANN, J
    DALCHAU, R
    FABRE, JW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (06) : 1521 - 1529
  • [10] HARRIS PE, 1992, J IMMUNOL, V148, P2169